| 000 | 01157 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515023042.0 | ||
| 264 | 0 | _c20060802 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0731-7085 | ||
| 024 | 7 |
_a10.1016/j.jpba.2006.03.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGavin, Peter F | |
| 245 | 0 | 0 |
_aA quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materials. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical and biomedical analysis _cJun 2006 |
||
| 300 |
_a1251-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aChemistry, Pharmaceutical _xmethods |
| 650 | 0 | 4 |
_aChromatography, Liquid _xmethods |
| 650 | 0 | 4 | _aDrug Contamination |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xanalysis |
| 650 | 0 | 4 | _aQuality Control |
| 700 | 1 | _aOlsen, Bernard A | |
| 700 | 1 | _aWirth, David D | |
| 700 | 1 | _aLorenz, Kurt T | |
| 773 | 0 |
_tJournal of pharmaceutical and biomedical analysis _gvol. 41 _gno. 4 _gp. 1251-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpba.2006.03.013 _zAvailable from publisher's website |
| 999 |
_c16225992 _d16225992 |
||